CAVHANZA vs IBRANCE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 6, 2026·How we rate

Possible drug interaction. CAVHANZA and IBRANCE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CAVHANZA	IBRANCE
Rating	New	60/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	NILOTINIB	PALBOCICLIB
Manufacturer	Flex Pharma	Pfizer
Dosage forms	Tablet, orally disintegrating	Capsule, Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	Boxed warning	None
Treats	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors	Breast Neoplasms

cavhanza ibrance

Rating

New

60/100

Pharmacy pays

—

Type

Active ingredient

NILOTINIB

PALBOCICLIB

Manufacturer

Flex Pharma

Pfizer

Dosage forms

Tablet, orally disintegrating

Capsule, Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

Breast Neoplasms

Frequently asked questions

What is the difference between Cavhanza and Ibrance?

Cavhanza contains Nilotinib, while Ibrance contains Palbociclib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.